Glucose Control During Labour and Delivery in Type 1 Diabetes - An Update on Current Evidence

Overview

Journal Curr Diab Rep

Publisher Current Science

Specialty Endocrinology

Date 2024 Nov 22

PMID 39576400

Authors

Lene Ringholm

Julie Carstens Soholm

Berit Woetmann Pedersen

Tine Dalsgaard Clausen

Peter Damm

Elisabeth Reinhardt Mathiesen

Affiliations

Soon will be listed here.

Abstract

Purpose Of Review: To provide an update on diabetes management during labour and delivery in women with type 1 diabetes with focus on appropriate insulin administration, carbohydrate supply and use of diabetes technology to support safe delivery and neonatal well-being.

Recent Findings: During active labour and elective cesarean section capillary blood glucose monitoring or continuous glucose monitoring at least hourly is recommended. Infusion with isotonic (5%) glucose can be given with adjustable infusion rate to address maternal carbohydrate requirements and to prevent maternal hypoglycemia. Subcutaneous insulin administration with multiple injections or insulin pump therapy is considered at least as safe and efficient as intravenous administration to obtain tight glycemic targets. Automated insulin delivery via insulin pump can be continued during labour and delivery. Diabetes management during labour and delivery involves intensive glucose monitoring, adequate insulin administration and carbohydrate administration to support safe delivery and neonatal well-being.

References

Seaquist E, Anderson J, Childs B, Cryer P, Dagogo-Jack S, Fish L . Hypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and the Endocrine Society. Diabetes Care. 2013; 36(5):1384-95. PMC: 3631867. DOI: 10.2337/dc12-2480. View

Keller M, Vestgaard M, Damm P, Mathiesen E, Ringholm L . Treatment with the long-acting insulin analog degludec during pregnancy in women with type 1 diabetes: An observational study of 22 cases. Diabetes Res Clin Pract. 2019; 152:58-64. DOI: 10.1016/j.diabres.2019.05.004. View

Benhalima K, Beunen K, Siegelaar S, Painter R, Murphy H, Feig D . Management of type 1 diabetes in pregnancy: update on lifestyle, pharmacological treatment, and novel technologies for achieving glycaemic targets. Lancet Diabetes Endocrinol. 2023; 11(7):490-508. DOI: 10.1016/S2213-8587(23)00116-X. View

Ekbom P, Damm P, Feldt-Rasmussen B, Feldt-Rasmussen U, Jensen D, Mathiesen E . Elevated third-trimester haemoglobin A 1c predicts preterm delivery in type 1 diabetes. J Diabetes Complications. 2008; 22(5):297-302. DOI: 10.1016/j.jdiacomp.2007.03.008. View

Glinianaia S, Tennant P, Bilous R, Rankin J, Bell R . HbA(1c) and birthweight in women with pre-conception type 1 and type 2 diabetes: a population-based cohort study. Diabetologia. 2012; 55(12):3193-203. DOI: 10.1007/s00125-012-2721-z. View

Murphy H, Howgate C, OKeefe J, Myers J, Morgan M, Coleman M . Characteristics and outcomes of pregnant women with type 1 or type 2 diabetes: a 5-year national population-based cohort study. Lancet Diabetes Endocrinol. 2021; 9(3):153-164. DOI: 10.1016/S2213-8587(20)30406-X. View

Norgaard S, Vestgaard M, Jorgensen I, Asbjornsdottir B, Ringholm L, McIntyre H . Diastolic blood pressure is a potentially modifiable risk factor for preeclampsia in women with pre-existing diabetes. Diabetes Res Clin Pract. 2018; 138:229-237. DOI: 10.1016/j.diabres.2018.02.014. View

Mackin S, Nelson S, Kerssens J, Wood R, Wild S, Colhoun H . Diabetes and pregnancy: national trends over a 15 year period. Diabetologia. 2018; 61(5):1081-1088. PMC: 6448996. DOI: 10.1007/s00125-017-4529-3. View

Soholm J, Do N, Vestgaard M, Asbjornsdottir B, Norgaard S, Pedersen B . Falling Insulin Requirement in Pregnant Women With Diabetes Delivering Preterm: Prevalence, Predictors, and Consequences. J Clin Endocrinol Metab. 2022; 107(6):e2237-e2244. DOI: 10.1210/clinem/dgac159. View

10.

Feig D, Berger H, Donovan L, Godbout A, Kader T, Keely E . Diabetes and Pregnancy. Can J Diabetes. 2018; 42 Suppl 1:S255-S282. DOI: 10.1016/j.jcjd.2017.10.038. View

11.

Soholm J, Vestgaard M, Asbjornsdottir B, Do N, Pedersen B, Storgaard L . Potentially modifiable risk factors of preterm delivery in women with type 1 and type 2 diabetes. Diabetologia. 2021; 64(9):1939-1948. DOI: 10.1007/s00125-021-05482-8. View

12.

Secher A, Ringholm L, Andersen H, Damm P, Mathiesen E . The effect of real-time continuous glucose monitoring in pregnant women with diabetes: a randomized controlled trial. Diabetes Care. 2013; 36(7):1877-83. PMC: 3687305. DOI: 10.2337/dc12-2360. View

13.

Drever E, Tomlinson G, Bai A, Feig D . Insulin pump use compared with intravenous insulin during labour and delivery: the INSPIRED observational cohort study. Diabet Med. 2016; 33(9):1253-9. DOI: 10.1111/dme.13106. View

14.

LIGHT I, Keenan W, Sutherland J . Maternal intravenous glucose administration as a cause of hypoglycemia in the infant of the diabetic mother. Am J Obstet Gynecol. 1972; 113(3):345-50. DOI: 10.1016/0002-9378(72)90682-5. View

15.

Yamamoto J, Donovan L, Mohammad K, Wood S . Severe neonatal hypoglycaemia and intrapartum glycaemic control in pregnancies complicated by type 1, type 2 and gestational diabetes. Diabet Med. 2019; 37(1):138-146. PMC: 6916340. DOI: 10.1111/dme.14137. View

16.

Yamamoto J, Corcoy R, Donovan L, Stewart Z, Tomlinson G, Beardsall K . Maternal glycaemic control and risk of neonatal hypoglycaemia in Type 1 diabetes pregnancy: a secondary analysis of the CONCEPTT trial. Diabet Med. 2019; 36(8):1046-1053. DOI: 10.1111/dme.13988. View

17.

Cordua S, Secher A, Ringholm L, Damm P, Mathiesen E . Real-time continuous glucose monitoring during labour and delivery in women with Type 1 diabetes - observations from a randomized controlled trial. Diabet Med. 2013; 30(11):1374-81. DOI: 10.1111/dme.12246. View

18.

Avari P, ORegan A, Preechasuk L, Oliver N, Agha-Jaffar R . Adjustment of Maternal Variable Rate Insulin Infusions Using Real-Time Continuous Glucose Monitoring in Pregnant Women with Type 1 Diabetes. Diabetes Technol Ther. 2023; 25(4):293-297. DOI: 10.1089/dia.2022.0507. View

19.

Norgaard S, Mathiesen E, Norgaard K, Ringholm L . Comparison of Glycemic Metrics Measured Simultaneously by Intermittently Scanned Continuous Glucose Monitoring and Real-Time Continuous Glucose Monitoring in Pregnant Women with Type 1 Diabetes. Diabetes Technol Ther. 2021; 23(10):665-672. DOI: 10.1089/dia.2021.0109. View

20.

Rosenberg V, Eglinton G, Rauch E, Skupski D . Intrapartum maternal glycemic control in women with insulin requiring diabetes: a randomized clinical trial of rotating fluids versus insulin drip. Am J Obstet Gynecol. 2006; 195(4):1095-9. DOI: 10.1016/j.ajog.2006.05.051. View